期刊文献+

强化降脂治疗对青年冠心病患者PCI术后远期疗效的影响 被引量:1

下载PDF
导出
摘要 目的:探讨强化降脂治疗对经皮冠状动脉介入术(percutaneous coronary intervention,PCI)后的青年冠心病患者远期疗效的影响。方法:选取成功接受PCI治疗,术前血脂异常的青年冠心病患者为研究对象,260例患者随机分为观察组和对照组。对照组采用常规治疗方法,观察组采取强化治疗方法,比较对照组与观察组患者的主要终点事件及次要终点事件的组间差异性。结果:(1)两组随访12个月,观察组的甘油三酯和胆固醇水平均明显低于对照组(P<0.05);(2)随访12个月观察组终点事件总数明显低于对照组,差异有统计学意义(P<0.01)。结论:PCI术后强化降脂治疗可以降低青年冠心病患者心血管不良事件的风险,值得在临床上推广使用。
机构地区 巴彦淖尔市医院
出处 《包头医学院学报》 CAS 2015年第10期49-50,共2页 Journal of Baotou Medical College
  • 相关文献

参考文献5

  • 1李健斋 王抒 曾平.非高密度脂蛋白胆固醇用于评估及预测冠心病危险.中华血管病杂志,2008,12(5):56-57.
  • 2Prasad A, Singh M, Lerman A, et al. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long - term mortality [ J ]. J Am Call Cardiol, 2006,48 ( 9 ) : 1765 - 1770.
  • 3张茁.他汀类药物在脑卒中预防研究中的临床证据[J].中华老年心脑血管病杂志,2007,9(10):649-651. 被引量:14
  • 4黄宗燕,林英忠,刘伶,袁军.冠心病患者PCI术后支架内再狭窄的因素分析[J].中国现代医学杂志,2010,20(21):3331-3333. 被引量:18
  • 5Patti G, Paseeri V, Colonna G, et al. Atorvastatin pretreatmemimproves outcomes in patients with ACS undergoing early pereutaneous coronary intervention:results of the ABMYDA - ACS irandomized trial [ J ]. J Am Coli Cardio1,2007,49 : 1272 - 1278.

二级参考文献20

  • 1SIGWART U, PUEL J, MIRKOVITCH V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty[J]. N Engl J Med, 1987, 316(12): 701-706.
  • 2COLOMBO A, HALL P, NAKAMURA, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance[J]. Circulation, 1995, 91(6): 1676-1688.
  • 3SULLIVAN MD, LACROIX AZ, SPERTUS JA, et al. Depression predicts revascularization procedures for 5 years after coronary angiography[J]. Psychosom Med, 2003, 65(2): 229-236.
  • 4TOGNI M, WINDECKER S, COCCHIA RR, et al. Sirolimus-eluting stents associated with paradoxic Coronary vasoconstriction[J]. J Am Coil Cardiol, 2005, 46(2): 231-236.
  • 5TOGNI M, RABER L, COCCHIA R, et al. Local vascular dysfunction after coronary paclita.xel-eluting stent implantation[J]. Int J Cardiol, 2007, 120(2): 219-220.
  • 6NISHIO K, SAKURAI M, KUSUYAMA T, et al. A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes[J]. Diabetes Care, 2006, 29(1): 101-106.
  • 7Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease:The Scandinavian Survival Study (4S)[J]. Lancet, 1994,344 : 1383-1389.
  • 8Heart Protection Study Collaboration Group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals:A ramdomised placebocontrolled trial: Lancet, 2002,360 : 7-22.
  • 9Shepherd J, Blauw GJ, Murphy MB, et al. PROSPER study group PROspective Study of Pravastatin in the Elderly at Risk:Pravastatin in elderly individuals at risk of vascular disease (PROSPER) :A randomised controlled trial[J]. Lancet, 2002,360 : 1623-1630.
  • 10Saver PS, Dahlof B,Poulter NR, et al . Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA) :A multicentre randomized controlled trial[J]. Lancet,2003,361 : 1149-1158.

共引文献31

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部